Failure of host axons to regenerate through a once successful but later rejected long nerve allograft

The Journal of Comparative Neurology
A A ZalewskiA K Gulati

Abstract

Host axons will regenerate through a long nerve allograft in an immunologically tolerant rat. However, if tolerance is abolished, rejection occurs and allogeneic cells (e.g., Schwann, vascular, perineurial, etc.) as well as regenerated host axons disappear from the allograft. Because following tolerance abolition host axons begin to regenerate into the connective tissue remnants of the rejected nerve allografts, the extent of this renewed axonal growth was investigated. It was found that in a tolerance-abolished rat, host axons only regrew in to the proximal 1 cm of a 4-cm allograft which in a fully tolerant recipient would have had numerous allogeneic Schwann cell-myelinated axons throughout its length. It is concluded that viable allogenic cells (i.e., Schwann, fibroblast, and vascular) together with their connective tissue matrix provide the best way to aid host nerve fiber regeneration through a long nerve allograft.

References

Jan 1, 1978·Annual Review of Neuroscience·S S Varon, R P Bunge
Nov 1, 1977·Journal of Neurosurgery·R SinghS Stefanko
Jan 30, 1973·Acta Neuropathologica·J D Pollard, L Fitzpatrick
Nov 1, 1974·The American Journal of Anatomy·S Billings-GagliardiM F O'Connell
Mar 1, 1974·Plastic and Reconstructive Surgery·C D Bucko, D Steinmuller
Jan 1, 1964·International Review of Cytology·C C Speidel
Feb 1, 1980·Experimental Neurology·W F Windle
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·F Collins, J E Garrett
May 1, 1981·Experimental Neurology·A A ZalewskiW K Silvers
May 1, 1980·The Journal of Investigative Dermatology·H F DvorakS J Galli
Jul 30, 1981·The New England Journal of Medicine·T E StarzlG P Schröter
Jan 1, 1982·Muscle & Nerve·H MolanderI Eriksson
Jul 1, 1981·Muscle & Nerve·J D Pollard, J G McLeod
Jul 3, 1980·Nature·T EbendalK O Hedlund

❮ Previous
Next ❯

Citations

Jun 1, 1994·Progress in Neurobiology·P J EvansS E Mackinnon
Dec 1, 1984·Veterinary Parasitology·J HeineJ F Pohlenz
Apr 10, 2004·Neurological Research·Terence M Myckatyn, Susan E Mackinnon
Feb 2, 2002·Experimental Neurology·Afshin MosahebiGiorgio Terenghi
May 1, 1985·Experimental Neurology·L de MedinaceliY N Wang
Nov 1, 1983·Neuropathology and Applied Neurobiology·P N AndersonV V Stauber
Jan 1, 1989·Annales De Chirurgie De La Main : Organe Officiel Des Sociétés De Chirurgie De La Main·D KatzD Henin
May 1, 1991·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·T Trumble, J Stanislaw
Nov 1, 1994·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·T E TrumbleD Parvin
Apr 3, 2008·Microsurgery·Michael J BrennerSusan E Mackinnon
Apr 4, 2021·International Journal of Molecular Sciences·Tim KornfeldChristine Radtke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.